140 related articles for article (PubMed ID: 24928690)
1. A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine.
Lin G; Huang H; Liu T; He C; Liu J; Chen S; Hou J; Ren Z; Dong W; Wu Y
J Virol Methods; 2014 Sep; 206():89-94. PubMed ID: 24928690
[TBL] [Abstract][Full Text] [Related]
2. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
[TBL] [Abstract][Full Text] [Related]
3. A custom-made time-resolved fluoroimmunoassay for the quantitation of the host cell protein of Vero in rabies vaccine.
Yang Y; Li Z; Zhang Z; Zhai X; Li X; Cao Y; Fang H; He C; Wu Y; Lin G
J Virol Methods; 2023 Aug; 318():114752. PubMed ID: 37209780
[TBL] [Abstract][Full Text] [Related]
4. Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum.
Hou JY; Liu TC; Lin GF; Li ZX; Zou LP; Li M; Wu YS
Anal Chim Acta; 2012 Jul; 734():93-8. PubMed ID: 22704477
[TBL] [Abstract][Full Text] [Related]
5. A time-resolved fluoroimmunoassay for assessing rabies antibody titers in the sera of vaccinated human subjects.
Bian L; Zhao H; He C; Fang H; Chen Z; Lin L; Ye K; Wu Y; Lin G
Biologicals; 2020 Nov; 68():54-59. PubMed ID: 32868168
[TBL] [Abstract][Full Text] [Related]
6. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
[TBL] [Abstract][Full Text] [Related]
7. A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum.
Lin G; Liu T; Hou J; Ren Z; Zhou J; Liang Q; Chen Z; Dong W; Wu Y
J Fluoresc; 2015 Mar; 25(2):361-7. PubMed ID: 25666714
[TBL] [Abstract][Full Text] [Related]
8. Development of a Time and Cost Benefit Antibody Binding Test-Based Method for Determination of Rabies Vaccine Potency.
Asgary V; Mojtabavi N; Janani A; Mousavi T; Hadjati J; Khosravy MS; Ahangari Cohan R
Viral Immunol; 2017 Apr; 30(3):204-209. PubMed ID: 28118120
[TBL] [Abstract][Full Text] [Related]
9. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
10. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
[TBL] [Abstract][Full Text] [Related]
11. A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
Ye K; Shi D; Zhang Z; Bian L; Li Z; Liu T; He C; Xu S; Wu Y; Lin G
Vaccine; 2021 Dec; 39(51):7470-7476. PubMed ID: 34815118
[TBL] [Abstract][Full Text] [Related]
12. Determination of parvovirus antigen in the vaccine using time-resolved fluorescence immunoassay.
Chen C; Liang H; Hu B; Ning B; Lai H; He Y; Guo G; Zhong S; Li L
Biotechnol Appl Biochem; 2021 Jun; 68(3):597-602. PubMed ID: 32533780
[TBL] [Abstract][Full Text] [Related]
13. Development of a relative potency test using ELISA for human rabies vaccines.
Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
[TBL] [Abstract][Full Text] [Related]
14. Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein.
Nimmagadda SV; Aavula SM; Biradhar N; Rao VS; Shanmugham R; Chandran D; Thirumeni N; Singanallur NB; Villuppanoor SA
Clin Vaccine Immunol; 2010 Aug; 17(8):1261-8. PubMed ID: 20573881
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of rabies antigen by ELISA.
van der Marel P; van Wezel AL
Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
[TBL] [Abstract][Full Text] [Related]
16. Development of a dual-label time-resolved fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen.
Lin GF; Liu TC; Zou LP; Hou JY; Wu YS
Luminescence; 2013; 28(3):401-6. PubMed ID: 22715159
[TBL] [Abstract][Full Text] [Related]
17. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
[TBL] [Abstract][Full Text] [Related]
18. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
Jallet C; Tordo N
J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
[TBL] [Abstract][Full Text] [Related]
19. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
[TBL] [Abstract][Full Text] [Related]
20. An ELISA-like time-resolved fluorescence immunoassay for microcystin detection.
Lei LM; Wu YS; Gan NQ; Song LR
Clin Chim Acta; 2004 Oct; 348(1-2):177-80. PubMed ID: 15369752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
